Biological agents in cancer therapy: Cytokines, monoclonal antibodies and vaccines - 21st Symposium of the Gesellschaft zur Bekämpfung der Krebskrankheiten (GBK), Nordrhein-Westfalen, Düsseldorf, June 1989 Journal Article


Author: Oettgen, H. F.
Article Title: Biological agents in cancer therapy: Cytokines, monoclonal antibodies and vaccines - 21st Symposium of the Gesellschaft zur Bekämpfung der Krebskrankheiten (GBK), Nordrhein-Westfalen, Düsseldorf, June 1989
Abstract: Biological approaches to cancer therapy have gone through phases of early excitement and subsequent neglect and ridicule, and have now entered an era of renewed interest. Unlike Coley and his contemporaries a century ago we are using highly purified agents of impressive potency and specificity of action in our current studies. We have come a long way in dissecting their interactions in inflammation, immunity and hematopoiesis, but we have a long way to go in defining optimal conditions for their use in therapy. However one judges the promise biological agents hold for cancer therapy, it seems certain that they will be prominent subjects of future research. © 1990 Springer-Verlag.
Keywords: unclassified drug; interferon; conference paper; neoplasms; bcg vaccine; interleukin 2; cancer immunotherapy; monoclonal antibody; cytokines; antibodies, monoclonal; immunotherapy; cancer vaccine; granulocyte colony-stimulating factor; colony-stimulating factors; interleukin-2; tumor necrosis factor; biological factors; interferons; human; ganglioside gm4
Journal Title: Journal of Cancer Research and Clinical Oncology
Volume: 116
Issue: 1
ISSN: 0171-5216
Publisher: Springer  
Date Published: 1990-01-01
Start Page: 116
End Page: 119
Language: English
DOI: 10.1007/bf01612653
PUBMED: 1690209
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Herbert F Oettgen
    130 Oettgen